EPISODE · Dec 16, 2020 · 6 MIN
GRACEcast - LCVL - Leading treatment options for patients with low or negative tumor PD-L1 expression and advanced squamous NSCLC today
from GRACEcast - Discussions with the Global Resource for Advancing Cancer Education · host cancerGRACE
Dr. Matthew Gubens discusses Targeted therapies in NSCLC PD-L1 Expression and the leading treatment options for patients with low or negative tumor PD-L1 expression and advanced squamous NSCLC today
Embed this episode
NOW PLAYING
GRACEcast - LCVL - Leading treatment options for patients with low or negative tumor PD-L1 expression and advanced squamous NSCLC today
0:00
6:52
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of GRACEcast - Discussions with the Global Resource for Advancing Cancer Education?
This episode is 6 minutes long.
When was this GRACEcast - Discussions with the Global Resource for Advancing Cancer Education episode published?
This episode was published on December 16, 2020.
Can I download this GRACEcast - Discussions with the Global Resource for Advancing Cancer Education episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!